NCT00086606View on ClinicalTrials.gov

A Safety and Efficacy Study of Xolair in Peanut Allergy

PHASE2TerminatedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

April 30, 2006

Conditions
Allergy
Interventions
DRUG

Xolair (omalizumab)

Trial Locations (1)

80012

Trial Information Support Line, Denver

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY